Journal Responds to Controversy Over Embryo Gene-Editing Paper
By Jocelyn Kaiser,
Science Magazine
| 04. 28. 2015
Untitled Document
The journal that days ago published the first-ever paper on an attempt to genetically modify human embryos has come out in defense of its decision and rebuffed claims that the paper was not adequately peer reviewed.
The paper appeared online on 18 April in Protein & Cell, which is co-published by Springer and an affiliate of China’s Ministry of Education. Junjiu Huang and colleagues at Sun Yat-sen University in Guangzhou describe their efforts to use the CRISPR-Cas9 gene-editing technology to alter a gene in abnormal human embryos. Their gene-editing effort was not very successful and introduced many unintentional mutations.
The paper has touched off a furor from scientists and others who have called for a moratorium on any efforts to establish a pregnancy with such a genetically modified embryo. Many have deemed Huang’s experiment unethical, and Huang himself has reportedly said that the paper was rejected by Science and Nature in part for ethical reasons.
This week, Protein & Cell defended its decision to publish the paper. An editorial posted online on 28 April says the journal’s...
Related Articles
By Roxanne Khamsi, The Atlantic | 07.07.2026
When Ludivine Verboogen and Romain Alderweireldt’s third child was born in Belgium in late 2015, they marveled at his long fingers. Perhaps one day he will be a famous pianist, they thought. But soon Ludivine grew worried that her son...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Michael Le Page , New Scientist | 06.25.2026
We now know the master gene that controls embryonic development in people. Called NANOG, its role has been identified by making precise changes to the DNA of fertilised eggs using a technique called CRISPR base editing.
The discovery might lead...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
